Anpario plc (LON:ANP - Get Free Report) shares passed below its 200-day moving average during trading on Friday. The stock has a 200-day moving average of GBX 520.32 and traded as low as GBX 515. Anpario shares last traded at GBX 517, with a volume of 4,870 shares.
Analysts Set New Price Targets
A number of brokerages have weighed in on ANP. Shore Capital Group reissued a "house stock" rating on shares of Anpario in a research note on Monday, August 17th. Canaccord Genuity Group upped their target price on Anpario from GBX 570 to GBX 600 and gave the company a "buy" rating in a research report on Friday, September 11th. One investment analyst has rated the stock with a Buy rating. Based on data from MarketBeat.com, Anpario has an average rating of "Buy" and an average target price of GBX 600.
View Our Latest Analysis on Anpario
Anpario Trading Up 0.4%
The business has a 50 day moving average of GBX 507.18 and a two-hundred day moving average of GBX 520.32. The firm has a market cap of £83.99 million, a P/E ratio of 13.10 and a beta of 1.05. The company has a current ratio of 6.29, a quick ratio of 5.16 and a debt-to-equity ratio of 0.60.
Anpario (LON:ANP - Get Free Report) last released its quarterly earnings data on Wednesday, September 9th. The company reported GBX 22.45 EPS for the quarter. Anpario had a net margin of 14.53% and a return on equity of 17.05%. Analysts predict that Anpario plc will post 23.58 earnings per share for the current year.
About Anpario
(
Get Free Report)
Anpario plc, together with its subsidiaries, engages in the production and distribution of natural feed additives for animal health, hygiene, and nutrition. Its health and performance category offers various products that support and maintain animal gut health, such as phytogenic and acid based eubiotics, and omega fatty acids under the Orego-Stim, Optomega, pHorce, Salkil, and Genex brands; feed quality category provides products, such as enzymes, antioxidants, pellet binders, mould inhibitors, and acid based eubiotics under the pHorce, Feedzyme, Salgard, Oxigard, Moldgard, and Mastercube brands.
Read More
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Anpario, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Anpario wasn't on the list.
While Anpario currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Oil still powers the global economy, but AI is reshaping the energy opportunity. Discover seven stocks spanning traditional energy, infrastructure, and next-generation power.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.